The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for many primary care providers. Between 2011 and 2023, obesity-specific prescriptions for GLP-1s increased by 700%. Since then, roughly 1 in 5 Americans have reportedly taken these drugs to lose weight...
The Center For Mind & Esteem Development, Inc.
A Course In Personal & Professional Development
LoveNow360 for Self, Community & World
Engagement & Empowerment
Marvin Mack, Founder & Creative Direcotr
The Center For Mind & Esteem Development, Inc. A Course In Personal & Professional LoveNow360 for Self, Community & World Engagement & Empowerment Marvin Mack, Founder & Creative Director lovenow360.net
4109716235
personaldevelopment@me.com
Copyright © 2023 lovenow360worldnews. All Rights Reserved
